Bavarian Biotech Report 2011/2012 (7MB) - Bio M

ViroLogik GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Drug Development, Infectious DiseasesViroLogik develops innovative drugs for treatment of viral diseases with afocus on Hepatitis C, HIV and Influenza.ViroLogik devised a novel strategy to overcome the formation of drug-resistance.The approach aims at the inhibition of highly conserved host cell factorsmandatory for viral replication. This is in contrast to many current drugsthat target fast changing viral proteins and, hence, are prone to formation ofdrug resistance.ViroLogik obtained a licence for a highly promising drug candidate andowns a broad panel of patents and patent applications. Comprehensivepartnerships with leading research institutions, hospitals and pharmaceuticalcompanies secure access to valuable expertise, networks and resources.Contact:Karl AppelmannHenkestr. 91D-91052 ErlangenPhone: +49 (0) 9131 974434-0Fax: +49 (0) 9131 974434-43E-Mail: info@virologik.comInternet: www.virologik.devivoPharm Europe LtdCROKeywords: Bone / Joint Diseases, Metabolic Diseases, Oncology, DrugDevelopment, Medical Writing, Pharmacology, ToxicologyvivoPharm is a contract research organisation (CRO) based in Australia. Itoffers integrated preclinical services to the biotechnology and pharmaceuticalindustries, which include in vitro and in vivo efficacy, safety, toxicology(GLP), pharmacodynamic and pharmacokinetic analyses.The company’s advanced animal facilities, laboratories and corporate headquartersare located in Adelaide, Australia. Its European office is based inMunich, Germany. vivoPharm works closely with its clients to develop a flexibleexperimental design to best serve each customer’s individual needs.vivoPharm operations are GLP compliant and meet the highest industrialstandards, acknowledged by customers worldwide.Contact:Dr. Katja WosikowskiGrillparzerstr. 25D-81675 MünchenPhone: + 49 (0) 89 552797-590Fax: + 49 (0) 89 552797-599E-Mail: info@vivopharm.euInternet: www.vivoPharm.euWacker Chemie AGCHEMICAL INDUSTRY & INDUSTRIAL BIOTECHNOLOGYKeywords: Nutraceuticals, Peptide/Protein, Antibody Production Service,Fine Chemicals / ReagentsWACKER is a globally active chemical company headquartered in Munich,Germany. With a wide range of state-of-the-art specialty products, WACKERis a leader in numerous industrial sectors. Its products are required incountless high-growth end-user sectors such as photovoltaics, electronics,pharmaceuticals and household/personal care products.Within its bio division, WACKER uses advanced biotech processes to offerinnovative and tailored solutions and biotech products for the pharma andthe food & nutrition industry. Its products include pharmaceutical proteins,cyclodextrins and fermentation-grade cysteine. The division focuses ondeveloping customized solutions for growth sectors such as food additivesand pharmaceutical actives.Contact:Rachela MohrHanns-Seidel-Platz 4D-81737 MünchenPhone: +49 (0) 89 6279-0Fax: +49 (0) 89 6279-1770E-Mail: info@wacker.comInternet: www.wacker.com119